nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ALB—melanoma	0.23	0.512	CbGaD
Enzalutamide—ABCB1—melanoma	0.22	0.488	CbGaD
Enzalutamide—ALB—Vemurafenib—melanoma	0.114	0.304	CbGbCtD
Enzalutamide—CYP3A4—Temozolomide—melanoma	0.0653	0.174	CbGbCtD
Enzalutamide—CYP2D6—Vemurafenib—melanoma	0.0563	0.15	CbGbCtD
Enzalutamide—ABCB1—Dactinomycin—melanoma	0.0397	0.106	CbGbCtD
Enzalutamide—CYP3A4—Vemurafenib—melanoma	0.0358	0.0953	CbGbCtD
Enzalutamide—CYP3A5—Docetaxel—melanoma	0.0315	0.0839	CbGbCtD
Enzalutamide—ABCB1—Docetaxel—melanoma	0.0205	0.0546	CbGbCtD
Enzalutamide—CYP3A4—Docetaxel—melanoma	0.0123	0.0327	CbGbCtD
Enzalutamide—Lung infection—Temozolomide—melanoma	0.00812	0.0749	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Vemurafenib—melanoma	0.00264	0.0243	CcSEcCtD
Enzalutamide—Lower respiratory tract infection—Docetaxel—melanoma	0.00259	0.0239	CcSEcCtD
Enzalutamide—Dry skin—Vemurafenib—melanoma	0.00173	0.016	CcSEcCtD
Enzalutamide—Memory impairment—Temozolomide—melanoma	0.0017	0.0157	CcSEcCtD
Enzalutamide—Disturbance in attention—Temozolomide—melanoma	0.00154	0.0142	CcSEcCtD
Enzalutamide—Infestation NOS—Vemurafenib—melanoma	0.00146	0.0135	CcSEcCtD
Enzalutamide—Infestation—Vemurafenib—melanoma	0.00146	0.0135	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Temozolomide—melanoma	0.00135	0.0124	CcSEcCtD
Enzalutamide—Oedema peripheral—Vemurafenib—melanoma	0.00129	0.0119	CcSEcCtD
Enzalutamide—Connective tissue disorder—Vemurafenib—melanoma	0.00129	0.0119	CcSEcCtD
Enzalutamide—Sepsis—Dactinomycin—melanoma	0.00128	0.0118	CcSEcCtD
Enzalutamide—Injury—Bleomycin—melanoma	0.00125	0.0115	CcSEcCtD
Enzalutamide—Sepsis—Carmustine—melanoma	0.0012	0.011	CcSEcCtD
Enzalutamide—Angiopathy—Vemurafenib—melanoma	0.00119	0.011	CcSEcCtD
Enzalutamide—Back pain—Vemurafenib—melanoma	0.0011	0.0102	CcSEcCtD
Enzalutamide—Injury—Carmustine—melanoma	0.00109	0.01	CcSEcCtD
Enzalutamide—Amnesia—Carmustine—melanoma	0.00107	0.00983	CcSEcCtD
Enzalutamide—Hot flush—Temozolomide—melanoma	0.00103	0.00954	CcSEcCtD
Enzalutamide—Amnesia—Temozolomide—melanoma	0.00103	0.00949	CcSEcCtD
Enzalutamide—Menopausal symptoms—Temozolomide—melanoma	0.00103	0.00945	CcSEcCtD
Enzalutamide—Arthralgia—Vemurafenib—melanoma	0.00097	0.00895	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000964	0.00889	CcSEcCtD
Enzalutamide—Infection—Vemurafenib—melanoma	0.000924	0.00852	CcSEcCtD
Enzalutamide—Nervous system disorder—Vemurafenib—melanoma	0.000912	0.00841	CcSEcCtD
Enzalutamide—Skin disorder—Vemurafenib—melanoma	0.000904	0.00833	CcSEcCtD
Enzalutamide—Pneumonia—Bleomycin—melanoma	0.000889	0.0082	CcSEcCtD
Enzalutamide—Dry skin—Temozolomide—melanoma	0.000887	0.00818	CcSEcCtD
Enzalutamide—Muscular weakness—Carmustine—melanoma	0.000883	0.00814	CcSEcCtD
Enzalutamide—Neutropenia—Dactinomycin—melanoma	0.000864	0.00797	CcSEcCtD
Enzalutamide—Muscular weakness—Temozolomide—melanoma	0.000853	0.00787	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000848	0.00782	CcSEcCtD
Enzalutamide—Haematuria—Bleomycin—melanoma	0.000843	0.00777	CcSEcCtD
Enzalutamide—Pneumonia—Dactinomycin—melanoma	0.000829	0.00764	CcSEcCtD
Enzalutamide—Neutropenia—Carmustine—melanoma	0.000809	0.00746	CcSEcCtD
Enzalutamide—Bronchitis—Temozolomide—melanoma	0.000804	0.00741	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Vemurafenib—melanoma	0.000803	0.00741	CcSEcCtD
Enzalutamide—Fatigue—Vemurafenib—melanoma	0.000802	0.0074	CcSEcCtD
Enzalutamide—Hypoaesthesia—Bleomycin—melanoma	0.000789	0.00728	CcSEcCtD
Enzalutamide—Neutropenia—Temozolomide—melanoma	0.000782	0.00721	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Temozolomide—melanoma	0.000777	0.00717	CcSEcCtD
Enzalutamide—Pneumonia—Carmustine—melanoma	0.000776	0.00716	CcSEcCtD
Enzalutamide—Pollakiuria—Temozolomide—melanoma	0.000772	0.00712	CcSEcCtD
Enzalutamide—Sepsis—Docetaxel—melanoma	0.000769	0.00709	CcSEcCtD
Enzalutamide—Pneumonia—Temozolomide—melanoma	0.00075	0.00691	CcSEcCtD
Enzalutamide—Infestation NOS—Temozolomide—melanoma	0.000745	0.00687	CcSEcCtD
Enzalutamide—Infestation—Temozolomide—melanoma	0.000745	0.00687	CcSEcCtD
Enzalutamide—Pharyngitis—Dactinomycin—melanoma	0.000734	0.00677	CcSEcCtD
Enzalutamide—Sinusitis—Temozolomide—melanoma	0.000699	0.00645	CcSEcCtD
Enzalutamide—Hypoaesthesia—Carmustine—melanoma	0.000689	0.00635	CcSEcCtD
Enzalutamide—Hot flush—Docetaxel—melanoma	0.000688	0.00634	CcSEcCtD
Enzalutamide—Oedema peripheral—Carmustine—melanoma	0.000682	0.00629	CcSEcCtD
Enzalutamide—Menopausal symptoms—Docetaxel—melanoma	0.000682	0.00629	CcSEcCtD
Enzalutamide—Connective tissue disorder—Carmustine—melanoma	0.000681	0.00628	CcSEcCtD
Enzalutamide—Asthenia—Vemurafenib—melanoma	0.000667	0.00616	CcSEcCtD
Enzalutamide—Hypoaesthesia—Temozolomide—melanoma	0.000666	0.00614	CcSEcCtD
Enzalutamide—Pharyngitis—Temozolomide—melanoma	0.000664	0.00612	CcSEcCtD
Enzalutamide—Urinary tract disorder—Temozolomide—melanoma	0.000661	0.00609	CcSEcCtD
Enzalutamide—Oedema peripheral—Temozolomide—melanoma	0.000659	0.00608	CcSEcCtD
Enzalutamide—Pruritus—Vemurafenib—melanoma	0.000658	0.00607	CcSEcCtD
Enzalutamide—Connective tissue disorder—Temozolomide—melanoma	0.000658	0.00606	CcSEcCtD
Enzalutamide—Urethral disorder—Temozolomide—melanoma	0.000656	0.00605	CcSEcCtD
Enzalutamide—Diarrhoea—Vemurafenib—melanoma	0.000637	0.00587	CcSEcCtD
Enzalutamide—Leukopenia—Bleomycin—melanoma	0.000618	0.0057	CcSEcCtD
Enzalutamide—Dizziness—Vemurafenib—melanoma	0.000615	0.00567	CcSEcCtD
Enzalutamide—Angiopathy—Temozolomide—melanoma	0.000607	0.0056	CcSEcCtD
Enzalutamide—Mental disorder—Carmustine—melanoma	0.000607	0.00559	CcSEcCtD
Enzalutamide—Dry skin—Docetaxel—melanoma	0.00059	0.00544	CcSEcCtD
Enzalutamide—Mental disorder—Temozolomide—melanoma	0.000586	0.00541	CcSEcCtD
Enzalutamide—Back pain—Carmustine—melanoma	0.000583	0.00538	CcSEcCtD
Enzalutamide—Headache—Vemurafenib—melanoma	0.000583	0.00537	CcSEcCtD
Enzalutamide—Leukopenia—Dactinomycin—melanoma	0.000577	0.00532	CcSEcCtD
Enzalutamide—Nasopharyngitis—Docetaxel—melanoma	0.000575	0.0053	CcSEcCtD
Enzalutamide—Back pain—Temozolomide—melanoma	0.000564	0.0052	CcSEcCtD
Enzalutamide—Infection—Bleomycin—melanoma	0.00056	0.00516	CcSEcCtD
Enzalutamide—Thrombocytopenia—Bleomycin—melanoma	0.000552	0.00509	CcSEcCtD
Enzalutamide—Leukopenia—Carmustine—melanoma	0.00054	0.00498	CcSEcCtD
Enzalutamide—Vertigo—Temozolomide—melanoma	0.000523	0.00483	CcSEcCtD
Enzalutamide—Convulsion—Carmustine—melanoma	0.000522	0.00482	CcSEcCtD
Enzalutamide—Infection—Dactinomycin—melanoma	0.000522	0.00482	CcSEcCtD
Enzalutamide—Leukopenia—Temozolomide—melanoma	0.000521	0.00481	CcSEcCtD
Enzalutamide—Hypertension—Carmustine—melanoma	0.00052	0.0048	CcSEcCtD
Enzalutamide—Neutropenia—Docetaxel—melanoma	0.00052	0.00479	CcSEcCtD
Enzalutamide—Thrombocytopenia—Dactinomycin—melanoma	0.000515	0.00475	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Bleomycin—melanoma	0.000514	0.00474	CcSEcCtD
Enzalutamide—Anxiety—Carmustine—melanoma	0.000511	0.00472	CcSEcCtD
Enzalutamide—Paraesthesia—Bleomycin—melanoma	0.000506	0.00467	CcSEcCtD
Enzalutamide—Convulsion—Temozolomide—melanoma	0.000505	0.00465	CcSEcCtD
Enzalutamide—Hypertension—Temozolomide—melanoma	0.000503	0.00464	CcSEcCtD
Enzalutamide—Pneumonia—Docetaxel—melanoma	0.000499	0.0046	CcSEcCtD
Enzalutamide—Arthralgia—Temozolomide—melanoma	0.000496	0.00457	CcSEcCtD
Enzalutamide—Infestation—Docetaxel—melanoma	0.000496	0.00457	CcSEcCtD
Enzalutamide—Infestation NOS—Docetaxel—melanoma	0.000496	0.00457	CcSEcCtD
Enzalutamide—Anxiety—Temozolomide—melanoma	0.000494	0.00456	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000493	0.00454	CcSEcCtD
Enzalutamide—Infection—Carmustine—melanoma	0.000489	0.00451	CcSEcCtD
Enzalutamide—Thrombocytopenia—Carmustine—melanoma	0.000482	0.00444	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000479	0.00442	CcSEcCtD
Enzalutamide—Infection—Temozolomide—melanoma	0.000472	0.00436	CcSEcCtD
Enzalutamide—Epistaxis—Docetaxel—melanoma	0.000468	0.00431	CcSEcCtD
Enzalutamide—Nervous system disorder—Temozolomide—melanoma	0.000466	0.0043	CcSEcCtD
Enzalutamide—Thrombocytopenia—Temozolomide—melanoma	0.000466	0.00429	CcSEcCtD
Enzalutamide—Skin disorder—Temozolomide—melanoma	0.000462	0.00426	CcSEcCtD
Enzalutamide—Fatigue—Dactinomycin—melanoma	0.000453	0.00418	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Carmustine—melanoma	0.000448	0.00413	CcSEcCtD
Enzalutamide—Rhinitis—Docetaxel—melanoma	0.000446	0.00411	CcSEcCtD
Enzalutamide—Insomnia—Carmustine—melanoma	0.000445	0.0041	CcSEcCtD
Enzalutamide—Hypoaesthesia—Docetaxel—melanoma	0.000443	0.00408	CcSEcCtD
Enzalutamide—Paraesthesia—Carmustine—melanoma	0.000442	0.00407	CcSEcCtD
Enzalutamide—Pharyngitis—Docetaxel—melanoma	0.000442	0.00407	CcSEcCtD
Enzalutamide—Urinary tract disorder—Docetaxel—melanoma	0.00044	0.00405	CcSEcCtD
Enzalutamide—Oedema peripheral—Docetaxel—melanoma	0.000438	0.00404	CcSEcCtD
Enzalutamide—Connective tissue disorder—Docetaxel—melanoma	0.000437	0.00403	CcSEcCtD
Enzalutamide—Urethral disorder—Docetaxel—melanoma	0.000436	0.00402	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000433	0.00399	CcSEcCtD
Enzalutamide—Insomnia—Temozolomide—melanoma	0.00043	0.00397	CcSEcCtD
Enzalutamide—Paraesthesia—Temozolomide—melanoma	0.000427	0.00394	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Carmustine—melanoma	0.000425	0.00392	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Temozolomide—melanoma	0.00041	0.00379	CcSEcCtD
Enzalutamide—Fatigue—Temozolomide—melanoma	0.00041	0.00378	CcSEcCtD
Enzalutamide—Asthenia—Bleomycin—melanoma	0.000404	0.00373	CcSEcCtD
Enzalutamide—Angiopathy—Docetaxel—melanoma	0.000404	0.00372	CcSEcCtD
Enzalutamide—Pruritus—Bleomycin—melanoma	0.000399	0.00368	CcSEcCtD
Enzalutamide—Mental disorder—Docetaxel—melanoma	0.00039	0.0036	CcSEcCtD
Enzalutamide—Asthenia—Dactinomycin—melanoma	0.000377	0.00348	CcSEcCtD
Enzalutamide—Back pain—Docetaxel—melanoma	0.000375	0.00346	CcSEcCtD
Enzalutamide—Diarrhoea—Dactinomycin—melanoma	0.00036	0.00332	CcSEcCtD
Enzalutamide—Asthenia—Carmustine—melanoma	0.000353	0.00326	CcSEcCtD
Enzalutamide—Leukopenia—Docetaxel—melanoma	0.000347	0.0032	CcSEcCtD
Enzalutamide—Asthenia—Temozolomide—melanoma	0.000341	0.00315	CcSEcCtD
Enzalutamide—Diarrhoea—Carmustine—melanoma	0.000337	0.0031	CcSEcCtD
Enzalutamide—Pruritus—Temozolomide—melanoma	0.000336	0.0031	CcSEcCtD
Enzalutamide—Convulsion—Docetaxel—melanoma	0.000336	0.0031	CcSEcCtD
Enzalutamide—Hypertension—Docetaxel—melanoma	0.000334	0.00308	CcSEcCtD
Enzalutamide—Arthralgia—Docetaxel—melanoma	0.00033	0.00304	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000328	0.00302	CcSEcCtD
Enzalutamide—Dizziness—Carmustine—melanoma	0.000325	0.003	CcSEcCtD
Enzalutamide—Diarrhoea—Temozolomide—melanoma	0.000325	0.003	CcSEcCtD
Enzalutamide—Dizziness—Temozolomide—melanoma	0.000314	0.0029	CcSEcCtD
Enzalutamide—Infection—Docetaxel—melanoma	0.000314	0.0029	CcSEcCtD
Enzalutamide—Nervous system disorder—Docetaxel—melanoma	0.00031	0.00286	CcSEcCtD
Enzalutamide—Thrombocytopenia—Docetaxel—melanoma	0.00031	0.00285	CcSEcCtD
Enzalutamide—Headache—Carmustine—melanoma	0.000308	0.00284	CcSEcCtD
Enzalutamide—Skin disorder—Docetaxel—melanoma	0.000307	0.00283	CcSEcCtD
Enzalutamide—Headache—Temozolomide—melanoma	0.000298	0.00275	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000288	0.00266	CcSEcCtD
Enzalutamide—Insomnia—Docetaxel—melanoma	0.000286	0.00264	CcSEcCtD
Enzalutamide—Paraesthesia—Docetaxel—melanoma	0.000284	0.00262	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Docetaxel—melanoma	0.000273	0.00252	CcSEcCtD
Enzalutamide—Fatigue—Docetaxel—melanoma	0.000273	0.00251	CcSEcCtD
Enzalutamide—Asthenia—Docetaxel—melanoma	0.000227	0.00209	CcSEcCtD
Enzalutamide—Pruritus—Docetaxel—melanoma	0.000224	0.00206	CcSEcCtD
Enzalutamide—Diarrhoea—Docetaxel—melanoma	0.000216	0.00199	CcSEcCtD
Enzalutamide—Dizziness—Docetaxel—melanoma	0.000209	0.00193	CcSEcCtD
Enzalutamide—Headache—Docetaxel—melanoma	0.000198	0.00183	CcSEcCtD
Enzalutamide—ALB—Hemostasis—PIK3CG—melanoma	1.39e-05	0.000211	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—EGF—melanoma	1.38e-05	0.000208	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.36e-05	0.000206	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.35e-05	0.000205	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—VCAN—melanoma	1.35e-05	0.000204	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP17A1—melanoma	1.34e-05	0.000203	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—VCAN—melanoma	1.34e-05	0.000203	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PLA2G6—melanoma	1.34e-05	0.000203	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP17A1—melanoma	1.31e-05	0.000199	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PLA2G6—melanoma	1.31e-05	0.000198	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLCB4—melanoma	1.29e-05	0.000195	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.27e-05	0.000193	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IGF1—melanoma	1.27e-05	0.000193	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.27e-05	0.000192	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GNA11—melanoma	1.27e-05	0.000192	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.26e-05	0.000191	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.24e-05	0.000188	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—FASN—melanoma	1.24e-05	0.000188	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GNA11—melanoma	1.24e-05	0.000188	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PLA2G6—melanoma	1.23e-05	0.000186	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.23e-05	0.000186	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CD—melanoma	1.22e-05	0.000185	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.22e-05	0.000185	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PLA2G6—melanoma	1.22e-05	0.000185	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—SLC5A5—melanoma	1.22e-05	0.000185	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC6A11—melanoma	1.21e-05	0.000184	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIP4K2A—melanoma	1.21e-05	0.000184	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—FASN—melanoma	1.21e-05	0.000184	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—VCAN—melanoma	1.2e-05	0.000182	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.2e-05	0.000182	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—SLC5A5—melanoma	1.19e-05	0.000181	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTAP—melanoma	1.18e-05	0.000179	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GNAQ—melanoma	1.18e-05	0.000178	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CD44—melanoma	1.18e-05	0.000178	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—VCAN—melanoma	1.17e-05	0.000178	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CD44—melanoma	1.15e-05	0.000174	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GNAQ—melanoma	1.15e-05	0.000174	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.14e-05	0.000172	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP17A1—melanoma	1.14e-05	0.000172	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP17A1—melanoma	1.13e-05	0.000171	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP1B1—melanoma	1.13e-05	0.000171	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.12e-05	0.00017	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.11e-05	0.000169	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.11e-05	0.000168	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—VCAN—melanoma	1.1e-05	0.000167	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP1B1—melanoma	1.1e-05	0.000167	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.1e-05	0.000166	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—VCAN—melanoma	1.1e-05	0.000166	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GNA11—melanoma	1.07e-05	0.000163	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GNA11—melanoma	1.07e-05	0.000162	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CB—melanoma	1.07e-05	0.000162	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—LUM—melanoma	1.05e-05	0.000159	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PHGDH—melanoma	1.05e-05	0.000159	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—FASN—melanoma	1.05e-05	0.000159	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—FASN—melanoma	1.04e-05	0.000158	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.04e-05	0.000157	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—SLC5A5—melanoma	1.03e-05	0.000156	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HPSE—melanoma	1.03e-05	0.000156	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.03e-05	0.000156	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—SLC5A5—melanoma	1.03e-05	0.000156	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.01e-05	0.000154	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP17A1—melanoma	1.01e-05	0.000154	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CUBN—melanoma	1.01e-05	0.000153	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1e-05	0.000152	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.99e-06	0.000151	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GNAQ—melanoma	9.97e-06	0.000151	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CD44—melanoma	9.97e-06	0.000151	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GNAQ—melanoma	9.91e-06	0.00015	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CD44—melanoma	9.91e-06	0.00015	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP17A1—melanoma	9.89e-06	0.00015	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	9.87e-06	0.00015	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IL2—melanoma	9.79e-06	0.000148	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SDHD—melanoma	9.76e-06	0.000148	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—BSG—melanoma	9.76e-06	0.000148	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CSPG4—melanoma	9.76e-06	0.000148	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.76e-06	0.000148	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.7e-06	0.000147	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.67e-06	0.000147	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.62e-06	0.000146	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GNA11—melanoma	9.57e-06	0.000145	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP1B1—melanoma	9.56e-06	0.000145	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP1B1—melanoma	9.5e-06	0.000144	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GPAM—melanoma	9.46e-06	0.000143	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—FASN—melanoma	9.37e-06	0.000142	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GNA11—melanoma	9.34e-06	0.000142	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP17A1—melanoma	9.32e-06	0.000141	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ABCB1—melanoma	9.3e-06	0.000141	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP17A1—melanoma	9.24e-06	0.00014	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—SLC5A5—melanoma	9.21e-06	0.00014	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	9.16e-06	0.000139	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—FASN—melanoma	9.14e-06	0.000139	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.11e-06	0.000138	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ABCB1—melanoma	9.09e-06	0.000138	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	9e-06	0.000136	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—SLC5A5—melanoma	8.99e-06	0.000136	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GNAQ—melanoma	8.9e-06	0.000135	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CD44—melanoma	8.9e-06	0.000135	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MAPK3—melanoma	8.82e-06	0.000134	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GNA11—melanoma	8.8e-06	0.000133	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GNA11—melanoma	8.73e-06	0.000132	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.71e-06	0.000132	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GNAQ—melanoma	8.68e-06	0.000132	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CD44—melanoma	8.68e-06	0.000132	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.63e-06	0.000131	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—FASN—melanoma	8.61e-06	0.000131	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MYC—melanoma	8.58e-06	0.00013	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PRKCA—melanoma	8.55e-06	0.00013	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—FASN—melanoma	8.54e-06	0.000129	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP1B1—melanoma	8.53e-06	0.000129	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ERCC2—melanoma	8.48e-06	0.000129	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SLC5A5—melanoma	8.47e-06	0.000128	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.43e-06	0.000128	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SLC5A5—melanoma	8.4e-06	0.000127	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.39e-06	0.000127	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PRKCA—melanoma	8.36e-06	0.000127	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP1B1—melanoma	8.33e-06	0.000126	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—melanoma	8.32e-06	0.000126	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ERCC2—melanoma	8.29e-06	0.000126	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—NRAS—melanoma	8.22e-06	0.000125	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GNAQ—melanoma	8.18e-06	0.000124	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CD44—melanoma	8.18e-06	0.000124	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GNAQ—melanoma	8.11e-06	0.000123	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CD44—melanoma	8.11e-06	0.000123	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLA2G6—melanoma	8.04e-06	0.000122	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.94e-06	0.00012	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.87e-06	0.000119	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MAPK3—melanoma	7.87e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ABCB1—melanoma	7.87e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP1B1—melanoma	7.85e-06	0.000119	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ABCB1—melanoma	7.82e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP1B1—melanoma	7.78e-06	0.000118	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.53e-06	0.000114	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MAPK1—melanoma	7.49e-06	0.000114	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PRKCA—melanoma	7.24e-06	0.00011	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—VCAN—melanoma	7.22e-06	0.000109	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PRKCA—melanoma	7.2e-06	0.000109	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ERCC2—melanoma	7.18e-06	0.000109	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ERCC2—melanoma	7.14e-06	0.000108	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—KRAS—melanoma	7.07e-06	0.000107	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ABCB1—melanoma	7.02e-06	0.000106	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.86e-06	0.000104	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CG—melanoma	6.7e-06	0.000102	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CG—melanoma	6.55e-06	9.93e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CA—melanoma	6.5e-06	9.85e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARG—melanoma	6.47e-06	9.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PRKCA—melanoma	6.46e-06	9.8e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ABCB1—melanoma	6.46e-06	9.79e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ERCC2—melanoma	6.41e-06	9.72e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ABCB1—melanoma	6.4e-06	9.71e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARG—melanoma	6.32e-06	9.58e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PRKCA—melanoma	6.31e-06	9.56e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—melanoma	6.29e-06	9.53e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ERCC2—melanoma	6.26e-06	9.49e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP17A1—melanoma	6.09e-06	9.24e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—HRAS—melanoma	6.01e-06	9.11e-05	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—AKT1—melanoma	5.95e-06	9.02e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.95e-06	9.02e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PRKCA—melanoma	5.95e-06	9.01e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.92e-06	8.97e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ERCC2—melanoma	5.9e-06	8.94e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PRKCA—melanoma	5.89e-06	8.93e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CD—melanoma	5.89e-06	8.93e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ERCC2—melanoma	5.85e-06	8.86e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—melanoma	5.81e-06	8.81e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CD—melanoma	5.76e-06	8.73e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GNA11—melanoma	5.75e-06	8.72e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—melanoma	5.68e-06	8.62e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CG—melanoma	5.67e-06	8.6e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CG—melanoma	5.64e-06	8.55e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—FASN—melanoma	5.63e-06	8.54e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SLC5A5—melanoma	5.54e-06	8.4e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARG—melanoma	5.47e-06	8.3e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARG—melanoma	5.44e-06	8.25e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GNAQ—melanoma	5.35e-06	8.11e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CD44—melanoma	5.35e-06	8.11e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.31e-06	8.05e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—AKT1—melanoma	5.31e-06	8.05e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CB—melanoma	5.13e-06	7.78e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP1B1—melanoma	5.13e-06	7.77e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—melanoma	5.09e-06	7.71e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CG—melanoma	5.06e-06	7.67e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CB—melanoma	5.02e-06	7.61e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CD—melanoma	4.99e-06	7.56e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—melanoma	4.97e-06	7.54e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CD—melanoma	4.96e-06	7.52e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CG—melanoma	4.94e-06	7.49e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—melanoma	4.92e-06	7.46e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARG—melanoma	4.89e-06	7.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.84e-06	7.34e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARG—melanoma	4.77e-06	7.23e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CG—melanoma	4.66e-06	7.06e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CG—melanoma	4.62e-06	7e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARG—melanoma	4.49e-06	6.81e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARG—melanoma	4.46e-06	6.75e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CD—melanoma	4.45e-06	6.75e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTEN—melanoma	4.44e-06	6.72e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—melanoma	4.39e-06	6.66e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CB—melanoma	4.35e-06	6.59e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CD—melanoma	4.34e-06	6.59e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTEN—melanoma	4.34e-06	6.57e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CB—melanoma	4.32e-06	6.55e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—melanoma	4.31e-06	6.53e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—melanoma	4.29e-06	6.5e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—melanoma	4.28e-06	6.49e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCB1—melanoma	4.22e-06	6.4e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CD—melanoma	4.09e-06	6.21e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CD—melanoma	4.06e-06	6.15e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—melanoma	4.04e-06	6.13e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—melanoma	4.01e-06	6.07e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PRKCA—melanoma	3.89e-06	5.89e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CB—melanoma	3.88e-06	5.88e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ERCC2—melanoma	3.86e-06	5.84e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—melanoma	3.84e-06	5.83e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CB—melanoma	3.79e-06	5.74e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTEN—melanoma	3.76e-06	5.69e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—melanoma	3.75e-06	5.69e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTEN—melanoma	3.73e-06	5.66e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CB—melanoma	3.57e-06	5.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CB—melanoma	3.54e-06	5.36e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—melanoma	3.54e-06	5.36e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—melanoma	3.51e-06	5.31e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTEN—melanoma	3.35e-06	5.08e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTEN—melanoma	3.27e-06	4.96e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CA—melanoma	3.13e-06	4.74e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTEN—melanoma	3.08e-06	4.67e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CA—melanoma	3.06e-06	4.64e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTEN—melanoma	3.06e-06	4.63e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CG—melanoma	3.04e-06	4.62e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARG—melanoma	2.94e-06	4.45e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CD—melanoma	2.68e-06	4.06e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CA—melanoma	2.65e-06	4.02e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—melanoma	2.64e-06	4.01e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CA—melanoma	2.63e-06	3.99e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKT1—melanoma	2.56e-06	3.88e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKT1—melanoma	2.5e-06	3.79e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CA—melanoma	2.37e-06	3.59e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CB—melanoma	2.33e-06	3.54e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—melanoma	2.31e-06	3.5e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CA—melanoma	2.31e-06	3.5e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CA—melanoma	2.18e-06	3.3e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKT1—melanoma	2.16e-06	3.28e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CA—melanoma	2.16e-06	3.27e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKT1—melanoma	2.15e-06	3.26e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTEN—melanoma	2.02e-06	3.06e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKT1—melanoma	1.93e-06	2.93e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKT1—melanoma	1.89e-06	2.86e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKT1—melanoma	1.78e-06	2.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKT1—melanoma	1.76e-06	2.67e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CA—melanoma	1.42e-06	2.16e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKT1—melanoma	1.16e-06	1.76e-05	CbGpPWpGaD
